APA (7th ed.) Citation

SW, K., H, E., JY, L., MS, L., YM, K., TW, K., & SW, L. (2026). Dual PARP/Tankyrase Inhibition Enhances Antitumor Efficacy in PTEN-Deficient Endometrial Cancer. Journal of cellular and molecular medicine, 30(11), e71242. https://doi.org/10.1111/jcmm.71242

Chicago Style (17th ed.) Citation

SW, Kang, Eum H, Lee JY, Lee MS, Kim YM, Kim TW, and Lee SW. "Dual PARP/Tankyrase Inhibition Enhances Antitumor Efficacy in PTEN-Deficient Endometrial Cancer." Journal of Cellular and Molecular Medicine 30, no. 11 (2026): e71242. https://doi.org/10.1111/jcmm.71242.

MLA (9th ed.) Citation

SW, Kang, et al. "Dual PARP/Tankyrase Inhibition Enhances Antitumor Efficacy in PTEN-Deficient Endometrial Cancer." Journal of Cellular and Molecular Medicine, vol. 30, no. 11, 2026, p. e71242, https://doi.org/10.1111/jcmm.71242.